The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Programmable base editing of A•T to G•C in genomic DNA without DNA cleavage
Open accessAbstract
The spontaneous deamination of cytosine is a major source of transitions from C•G to T•A base pairs, which account for half of known pathogenic point mutations in humans. The ability to efficiently convert targeted A•T base pairs to G•C could therefore advance the study and treatment of genetic diseases. The deamination of adenine yields inosine, which is treated as guanine by polymerases, but no enzymes are known to deaminate adenine in DNA. Here we describe adenine base editors (ABEs) that mediate the conversion of A•T to G•C in genomic DNA. We evolved a transfer RNA adenosine deaminase to operate on DNA when fused to a catalytically impaired CRISPR-Cas9 mutant. Extensive directed evolution and protein engineering resulted in seventh-generation ABEs that convert targeted A•T base pairs efficiently to G•C (approximately 50% efficiency in human cells) with high product purity (typically at least 99.9%) and low rates of indels (typically no more than 0.1%). ABEs introduce point mutations more efficiently and cleanly, and with less off-target genome modification, than a current Cas9 nuclease-based method, and can install disease-correcting or disease-suppressing mutations in human cells. Together with previous base editors, ABEs enable the direct, programmable introduction of all four transition mutations without double-stranded DNA cleavage.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Using a seventh-generation evolved transfer RNA adenosine deaminase attached to dCas9, researchers demonstrated conversion of A*T base pairs to G*C base pairs in a targeted fashion at efficiencies of around 50% with few undesired mutations in human cells.”
From Delivering CRISPR: a review of the challenges and approaches (2018) · cites this paper as Gaudelli et al., 2017
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Adenine base editor (ABE), first described in 2017, generally does not induce DSBs (<1%) and is therefore a favorable alternative to Cas9 for single and multiplex gene knockouts.12,14”
From Adenine base editor for knockout of proteins: A practical guide from design to analysis with updated MultiEditRbatch (2026) · cites this paper as [14]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Yet, these mutations occur significantly more often in human disease than transversion mutations (62% transition vs 38% transversion29,63).”
From One-step generation of tumor models by base editor multiplexing in adult stem cell-derived organoids (2023) · cites this paper as [29]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“CBE converts cytosine to thymine”
From Off-target effects in CRISPR/Cas9 gene editing (2023) · cites this paper as Gaudelli et al., 2017
The cited source says what the claim attributes to it.
In the citing paper
“ABE catalyzes the editing from adenine to guanine”
From Off-target effects in CRISPR/Cas9 gene editing (2023) · cites this paper as Gaudelli et al., 2017
The cited source says what the claim attributes to it.
In the citing paper
“Base editors are one such tool, which couple Cas9 nickases with nucleotide deaminases to achieve single nucleotide conversion without introducing DSBs.”
From Off-target effects in CRISPR/Cas9 gene editing (2023) · cites this paper as Gaudelli et al., 2017
The cited source says what the claim attributes to it.
In the citing paper
“Next-generation CRISPR tools, such as base editors, use enzymes like cytidine or adenine deaminases fused to Cas9 to introduce single nucleotide variants (SNVs) without DSBs.12,13”
From Protocol to create isogenic disease models from adult stem cell-derived organoids using next-generation CRISPR tools (2024) · cites this paper as [13]
The cited source says what the claim attributes to it.
In the citing paper
“Fusing adenine deaminase (an evolved TadA heterodimer) to a nickase-Cas9 creates an adenine base editor (ABE) that mediates A > G base changes via an inosine intermediate29”
From One-step generation of tumor models by base editor multiplexing in adult stem cell-derived organoids (2023) · cites this paper as [29]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“The second study used CRISPR-Cas9-mediated genome editing to remove a mutation in exon 23 in the mdx mouse model of DMD, providing partial recovery of functional dystrophin protein in skeletal myofibers and cardiac muscle 25,26,49 .”
From The promise and challenge of therapeutic genome editing (2020) · cites this paper as [49]
Experimental — accuracy not yet measuredIn the citing paper
“Consistent with the literature1, ABE6.3 resulted in the highest A>G base editing efficiency at position A9 (6.9 ± 2.0%,2 µg ABE6.3) (Supplementary Fig. 1) and editing efficiency was dependent of the ABE enzyme concentration.”
From Adenine base editing in an adult mouse model of tyrosinaemia (2019) · cites this paper as [1]
In the citing paper
“Adenine BEs comprise an evolved Escherichia coli TadA (ecTadA*, a tRNA adenosine deaminase evolved to accept DNA substrate) and Cas9 nickase, and mediate A•T to G•C substitutions1.”
From Adenine base editing in an adult mouse model of tyrosinaemia (2019) · cites this paper as [1]
In the citing paper
“The ABE editing window occupies positions ~4–9 with the 1st, 5’ nucleotide (nt) of the candidate sgRNA counted as position 1 1.”
From Adenine base editing in an adult mouse model of tyrosinaemia (2019) · cites this paper as [1]
In the citing paper
“Point mutations are a frequent cause of genetic disease, with ~50% of disease point mutations being G:C>A:T 1.”
From Adenine base editing in an adult mouse model of tyrosinaemia (2019) · cites this paper as [1]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage
Komor, A. C., Kim, Y. B., Packer, M. S., Zuris, J. A., & Liu, D. R. (2016) · Nature · doi:10.1038/nature17946 · Cited by 5,437
Self-citationClinVar: public archive of interpretations of clinically relevant variants
Landrum, M. J., Lee, J. M., Benson, M., Brown, G., Chao, C., Chitipiralla, S., Gu, B., Hart, J., Hoffman, D., Hoover, J., et al. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkv1222 · Cited by 2,758
GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases
Tsai, S. Q., Zheng, Z., Nguyen, N. T., Liebers, M., Topkar, V. V., Thapar, V., Wyvekens, N., Khayter, C., Iafrate, A. J., Le, L. P., et al. (2015) · Nature Biotechnology · doi:10.1038/nbt.3117 · Cited by 2,268
Targeted nucleotide editing using hybrid prokaryotic and vertebrate adaptive immune systems
Nishida, K., Arazoe, T., Yachie, N., Banno, S., Kakimoto, M., Tabata, M., Mochizuki, M., Miyabe, A., Araki, M., Hara, K. Y., et al. (2016) · Science · doi:10.1126/science.aaf8729 · Cited by 1,349
Efficient introduction of specific homozygous and heterozygous mutations using CRISPR/Cas9
Paquet, D., Kwart, D., Chen, A., Sproul, A., Jacob, S., Teo, S., Olsen, K. M., Gregg, A., Noggle, S., & Tessier-Lavigne, M. (2016) · Nature · doi:10.1038/nature17664 · Cited by 951
Precise base editing in rice, wheat and maize with a Cas9-cytidine deaminase fusion
Zong, Y., Wang, Y., Li, C., Zhang, R., Chen, K., Ran, Y., Qiu, J., Wang, D., & Gao, C. (2017) · Nature Biotechnology · doi:10.1038/nbt.3811 · Cited by 896
Komor, A. C., Zhao, K. T., Packer, M. S., Gaudelli, N. M., Waterbury, A. L., Koblan, L. W., Kim, Y. B., Badran, A. H., & Liu, D. R. (2017) · Science Advances · doi:10.1126/sciadv.aao4774 · Cited by 783
Self-citationKim, Y. B., Komor, A. C., Levy, J. M., Packer, M. S., Zhao, K. T., & Liu, D. R. (2017) · Nature Biotechnology · doi:10.1038/nbt.3803 · Cited by 758
Self-citationA system for the continuous directed evolution of biomolecules
Esvelt, K. M., Carlson, J. C., & Liu, D. R. (2011) · Nature · doi:10.1038/nature09929 · Cited by 694
Self-citationUracil in DNA – occurrence, consequences and repair
Krokan, H. E., Drabløs, F., & Slupphaug, G. (2002) · Oncogene · doi:10.1038/sj.onc.1205996 · Cited by 500
Flagged first, then by citations
Cited by
Sorted by citations
Items 601–700 of 1,024
Genome Editing in iPSC-Based Neural Systems: From Disease Models to Future Therapeutic Strategies
McTague, A., Rossignoli, G., Ferrini, A., Barral, S., & Kurian, M. A. (2021) · Frontiers in Genome Editing · doi:10.3389/fgeed.2021.630600 · Cited by 67
In utero adenine base editing corrects multi-organ pathology in a lethal lysosomal storage disease
Bose, S. K., White, B. M., Kashyap, M. V., Dave, A., De Bie, F. R., Li, H., Singh, K., Menon, P., Wang, T., Teerdhala, S., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-24443-8 · Cited by 67
All I's on the RADAR : role of ADAR in gene regulation
Shevchenko, G., & Morris, K. V. (2018) · FEBS Letters · doi:10.1002/1873-3468.13093 · Cited by 67
Retroelement-Based Genome Editing and Evolution
Simon, A. J., Morrow, B. R., & Ellington, A. D. (2018) · ACS Synthetic Biology · doi:10.1021/acssynbio.8b00273 · Cited by 67
A modular cloning toolkit for genome editing in plants
Hahn, F., Korolev, A. V., Loures, L. S., & Nekrasov, V. (2020) · BMC Plant Biology · doi:10.1186/s12870-020-02388-2 · Cited by 72
A Cas-embedding strategy for minimizing off-target effects of DNA base editors
Liu, Y., Zhou, C., Huang, S., Dang, L., Yu, W., He, J., Zhou, Y., Mao, S., Tao, W., Zhang, Y., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-19690-0 · Cited by 70
Evolving AAV-delivered therapeutics towards ultimate cures
He, X., Urip, B. A., Zhang, Z., Ngan, C. C., & Feng, B. (2021) · Journal of Molecular Medicine · doi:10.1007/s00109-020-02034-2 · Cited by 70
Yoon, H. H., Ye, S., Lim, S., Jo, A., Lee, H., Hong, F., Lee, S. E., Oh, S., Kim, N., Kim, K., et al. (2022) · The CRISPR Journal · doi:10.1089/crispr.2021.0025 · Cited by 68
Liang, Y., Xie, J., Zhang, Q., Wang, X., Gou, S., Lin, L., Chen, T., Ge, W., Zhuang, Z., Lian, M., et al. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac353 · Cited by 68
Limb–Girdle Muscular Dystrophies Classification and Therapies
Bouchard, C., & Tremblay, J. P. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12144769 · Cited by 67
Strand-preferred base editing of organellar and nuclear genomes using CyDENT
Hu, J., Sun, Y., Li, B., Liu, Z., Wang, Z., Gao, Q., Guo, M., Liu, G., Zhao, K. T., & Gao, C. (2023) · Nature Biotechnology · doi:10.1038/s41587-023-01910-9 · Cited by 67
Xu, W., Zhang, S., Qin, H., & Yao, K. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05957-3 · Cited by 74
Homology-Directed Repair of a Defective Glabrous Gene in Arabidopsis With Cas9-Based Gene Targeting
Hahn, F., Eisenhut, M., Mantegazza, O., & Weber, A. P. M. (2018) · Frontiers in Plant Science · doi:10.3389/fpls.2018.00424 · Cited by 67
One-step generation of tumor models by base editor multiplexing in adult stem cell-derived organoids
Geurts, M. H., Gandhi, S., Boretto, M. G., Akkerman, N., Derks, L. L. M., van Son, G., Celotti, M., Harshuk-Shabso, S., Peci, F., Begthel, H., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-40701-3 · Cited by 66
“Yet, these mutations occur signi fi cantlymore often inhumandisease thantransversion mutations (62% transition vs 38% transversion 29,63 ).”
Genome Editing in Agriculture: Technical and Practical Considerations
Jansing, J., Schiermeyer, A., Schillberg, S., Fischer, R., & Bortesi, L. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20122888 · Cited by 66
A transient reporter for editing enrichment (TREE) in human cells
Standage-Beier, K., Tekel, S. J., Brookhouser, N., Schwarz, G., Nguyen, T., Wang, X., & Brafman, D. A. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz713 · Cited by 66
Therapeutic Editing of the TP53 Gene: Is CRISPR/Cas9 an Option?
Mirgayazova, R., Khadiullina, R., Chasov, V. V., Mingaleeva, R. N., Рифкатовна, М. Р., Rizvanov, A. A., & Bulatov, E. (2020) · Genes · doi:10.3390/genes11060704 · Cited by 68
Efficient CRISPR-mediated base editing in Agrobacterium spp.
Rodrigues, S. D., Karimi, M., Impens, L., Lerberge, E. V., Coussens, G., Aesaert, S., Rombaut, D., Holtappels, D., Ibrahim, H. M. M., MONTAGU, M. V., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2013338118 · Cited by 66
Easy-Prime: a machine learning–based prime editor design tool
Li, Y., Chen, J., Tsai, S. Q., & Cheng, Y. (2021) · Genome biology · doi:10.1186/s13059-021-02458-0 · Cited by 71
Targeted introduction of heritable point mutations into the plant mitochondrial genome
Forner, J., Kleinschmidt, D., Meyer, E. H., Fischer, A., Morbitzer, R., Lahaye, T., Schöttler, M. A., & Bock, R. (2022) · Nature Plants · doi:10.1038/s41477-022-01108-y · Cited by 66
High-throughput functional evaluation of human cancer-associated mutations using base editors
Kim, Y., Lee, S., Cho, S., Park, J., Chae, D., Park, T., Minna, J. D., & Kim, S. (2022) · Nature Biotechnology · doi:10.1038/s41587-022-01276-4 · Cited by 66
Adenine Base Editing In Vivo with a Single Adeno-Associated Virus Vector
Zhang, H., Bamidele, N., Liu, P., Ojelabi, O., Gao, X. D., Rodríguez, T., Cheng, H., Kelly, K. L., Watts, J. K., Xie, J., et al. (2022) · GEN Biotechnology · doi:10.1089/genbio.2022.0015 · Cited by 67
Use of zebrafish models to investigate rare human disease
Adamson, K. I., Sheridan, E. G., & Grierson, A. J. (2018) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2018-105358 · Cited by 70
Lineage tracing using a Cas9-deaminase barcoding system targeting endogenous L1 elements
Hwang, B., Lee, W., Yum, S.-Y., Jeon, Y., Cho, N., Jang, G., & Bang, D. (2019) · Nature Communications · doi:10.1038/s41467-019-09203-z · Cited by 65
Glaser, V., Flugel, C., Kath, J., Du, W., Drosdek, V., Franke, C., Stein, M., Pruß, A., Schmueck-Henneresse, M., Volk, H.-D., et al. (2023) · Genome biology · doi:10.1186/s13059-023-02928-7 · Cited by 65
Hu, Z., Zhang, C., Wang, S., Gao, S., Wei, J., Li, M., Hou, L., Mao, H., Wei, Y., Qi, T., et al. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab148 · Cited by 67
Self-citationGene editing and its applications in biomedicine
Li, G., Li, X., Zhuang, S., Wang, L., Zhu, Y., Chen, Y., Sun, W. C., Wu, Z., Zhou, Z. L., Chen, J., et al. (2022) · Science China Life Sciences · doi:10.1007/s11427-021-2057-0 · Cited by 66
CRISPR-Cas9-Based Technology and Its Relevance to Gene Editing in Parkinson’s Disease
Rahman, M. U., Bilal, M., Shah, J. A., Kaushik, A. K., Teissèdre, P., & Kujawska, M. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14061252 · Cited by 65
Recent Advances in Improving Gene-Editing Specificity through CRISPR–Cas9 Nuclease Engineering
Huang, X., Yang, D., Zhang, J., Xu, J., & Chen, Y. E. (2022) · Cells · doi:10.3390/cells11142186 · Cited by 68
Enabling technology and core theory of synthetic biology
Zhang, X., Liu, C., Dai, J., Yuan, Y., Gao, C., Feng, Y. F., Wu, B., Wei, P., You, C., Wang, X., et al. (2023) · Science China Life Sciences · doi:10.1007/s11427-022-2214-2 · Cited by 69
Morgan, M. A., & Shilatifard, A. (2023) · Science Advances · doi:10.1126/sciadv.adg6593 · Cited by 71
Palmieri, M., Pozzer, D., & Landsberger, N. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1172805 · Cited by 66
Evolution of CRISPR/Cas Systems for Precise Genome Editing
Hryhorowicz, M., Lipiński, D., & Zeyland, J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241814233 · Cited by 69
Developing a highly efficient and wildly adaptive CRISPR ‐SaCas9 toolset for plant genome editing
Qin, R., Li, J., Li, H., Zhang, Y., Liu, X., Miao, Y., Zhang, X., & Wei, P. (2018) · Plant Biotechnology Journal · doi:10.1111/pbi.13047 · Cited by 65
The CRISPR toolbox in medical mycology: State of the art and perspectives
Morio, F., Lombardi, L., & Butler, G. (2020) · PLoS Pathogens · doi:10.1371/journal.ppat.1008201 · Cited by 66
Structural insights into a high fidelity variant of SpCas9
Guo, M., Ren, K., Zhu, Y., Tang, Z., Wang, Y., Zhang, B., & Huang, Z. (2019) · Cell Research · doi:10.1038/s41422-018-0131-6 · Cited by 65
Engineer chimeric Cas9 to expand PAM recognition based on evolutionary information
Ma, D., Xu, Z., Zhang, Z., Chen, X., Zeng, X., Zhang, Y., Deng, T., Ren, M., Sun, Z., Jiang, R., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-08395-8 · Cited by 66
ACBE, a new base editor for simultaneous C-to-T and A-to-G substitutions in mammalian systems
Xie, J., Huang, X., Wang, X., Gou, S., Liang, Y., Chen, F., Li, N., Ouyang, Z., Zhang, Q., Ge, W., et al. (2020) · BMC Biology · doi:10.1186/s12915-020-00866-5 · Cited by 67
CRISPR-based transcriptional activation tool for silent genes in filamentous fungi
Mózsik, L., Hoekzema, M., de Kok, N. A. W., Bovenberg, R. A. L., Nygård, Y., & Driessen, A. J. M. (2021) · Scientific Reports · doi:10.1038/s41598-020-80864-3 · Cited by 68
Alamillo, J. M., López, C. M., Martínez-Rivas, F. J., Torralbo, F., Bulut, M., & Alseekh, S. (2023) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2022.102876 · Cited by 64
CRISPR-mediated acceleration of wheat improvement: advances and perspectives
Zhou, X., Zhao, Y., Ni, P., Ni, Z., Sun, Q., & Zong, Y. (2023) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2023.09.007 · Cited by 68
Engineering strategies to safely drive CAR T-cells into the future
Rossi, M., & Breman, E. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1411393 · Cited by 68
Base editing screens define the genetic landscape of cancer drug resistance mechanisms
Coelho, M. A., Strauß, M. E., Watterson, A., Cooper, S., Bhosle, S. G., Illuzzi, G., Karakoç, E., Dinçer, C., Vieira, S. F., Sharma, M., et al. (2024) · Nature Genetics · doi:10.1038/s41588-024-01948-8 · Cited by 65
Bolduc, V., Foley, A. R., Solomon-Degefa, H., Sarathy, A., Donkervoort, S. C., Hu, Y., Chen, G. S., Sizov, K., Nalls, M., Zhou, H., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.124403 · Cited by 68
Wang, Y., Liu, Y., Li, J., Yang, Y., Ni, X., Cheng, H., Huang, T., Guo, Y., Ma, H., Zheng, P., et al. (2019) · Biotechnology and Bioengineering · doi:10.1002/bit.27121 · Cited by 64
Non-viral transfection technologies for next-generation therapeutic T cell engineering
Raes, L., Smedt, S. C. D., Raemdonck, K., & Braeckmans, K. (2021) · Biotechnology Advances · doi:10.1016/j.biotechadv.2021.107760 · Cited by 67
Cas9-directed immune tolerance in humans—a model to evaluate regulatory T cells in gene therapy?
Wagner, D. L., Peter, L., & Schmueck-Henneresse, M. (2021) · Gene Therapy · doi:10.1038/s41434-021-00232-2 · Cited by 63
Perturbing proteomes at single residue resolution using base editing
Després, P. C., Dubé, A. K., Seki, M., Yachie, N., & Landry, C. R. (2020) · Nature Communications · doi:10.1038/s41467-020-15796-7 · Cited by 65
CRISPR-Cas9: A Promising Genome Editing Therapeutic Tool for Alzheimer’s Disease—A Narrative Review
Barman, N. C., Khan, M. N. M., Islam, M., Nain, Z., Roy, R. K., Haque, A., & BARMAN, S. K. (2020) · Neurology and Therapy · doi:10.1007/s40120-020-00218-z · Cited by 65
The CRISPR/Cas9 revolution continues: From base editing to prime editing in plant science
Li, Y., Li, W., & Li, J. (2021) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2021.05.001 · Cited by 67
Exploring C-To-G Base Editing in Rice, Tomato, and Poplar
Sretenovic, S., Liu, S., Li, G., Cheng, Y., Fan, T., Xu, Y., Zhou, J., Zheng, X., Coleman, G. D., Zhang, Y., et al. (2021) · Frontiers in Genome Editing · doi:10.3389/fgeed.2021.756766 · Cited by 63
Benchmarking of SpCas9 variants enables deeper base editor screens of BRCA1 and BCL2
Sangree, A. K., Griffith, A. L., Szegletes, Z. M., Roy, P., DeWeirdt, P. C., Hegde, M., McGee, A. V., Hanna, R. E., & Doench, J. G. (2022) · Nature Communications · doi:10.1038/s41467-022-28884-7 · Cited by 64
Genome editing and beyond: what does it mean for the future of plant breeding?
Vu, T. V., Das, S., Hensel, G., & Kim, J. (2022) · Planta · doi:10.1007/s00425-022-03906-2 · Cited by 65
Advances of Epigenetic Biomarkers and Epigenome Editing for Early Diagnosis in Breast Cancer
Sarvari, P., Sarvari, P., Ramírez‐Díaz, I., Mahjoubi, F., & Rubio, K. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23179521 · Cited by 68
Kim, H. S., Kweon, J., & Kim, Y. (2024) · Experimental & Molecular Medicine · doi:10.1038/s12276-024-01212-3 · Cited by 68
Development of a CRISPR/Cas9 System for Methylococcus capsulatus In Vivo Gene Editing
Tapscott, T., Guarnieri, M. T., & Henard, C. A. (2019) · Applied and Environmental Microbiology · doi:10.1128/aem.00340-19 · Cited by 65
Targeting glycosylation of PD-1 to enhance CAR-T cell cytotoxicity
Shi, X., Zhang, D., Li, F., Zhang, Z., Wang, S., Xuan, Y., Yü, P., & Zhang, Y. (2019) · Journal of Hematology & Oncology · doi:10.1186/s13045-019-0831-5 · Cited by 63
McGrath, E. L., Shin, H., Zhang, L., Phue, J., Wu, W. W., Shen, R., Jang, Y.-Y., Revollo, J. R., & Ye, Z. (2019) · Nature Communications · doi:10.1038/s41467-019-13342-8 · Cited by 63
Advances in detecting and reducing off-target effects generated by CRISPR-mediated genome editing
Li, J., Hong, S., Chen, W., Zuo, E., & Yang, H. (2019) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2019.11.002 · Cited by 66
Gene Editing and Genotoxicity: Targeting the Off-Targets
Blattner, G., Cavazza, A., Thrasher, A. J., & Turchiano, G. (2020) · Frontiers in Genome Editing · doi:10.3389/fgeed.2020.613252 · Cited by 64
Doerfler, P. A., Feng, R., Li, Y., Palmer, L. E., Porter, S. N., Bell, H. W., Crossley, M., Pruett‐Miller, S. M., Cheng, Y., & Weiss, M. J. (2021) · Nature Genetics · doi:10.1038/s41588-021-00904-0 · Cited by 67
CRISPR-Cas gene editing technology and its application prospect in medicinal plants
Guo, M., Chen, H., Dong, S., Zhang, Z., & Luo, H. (2022) · Chinese Medicine · doi:10.1186/s13020-022-00584-w · Cited by 66
Hoberecht, L., Perampalam, P., Lun, A. T. L., & Fortin, J. (2022) · Nature Communications · doi:10.1038/s41467-022-34320-7 · Cited by 66
Tong, H., Wang, H., Wang, X., Liu, N., Li, G., Wu, D., Li, Y., Jin, M., Li, H., Wei, Y., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-49343-5 · Cited by 63
Recent advances in therapeutic gene-editing technologies
Liu, D., Cao, D., & Han, R. (2025) · Molecular Therapy · doi:10.1016/j.ymthe.2025.03.026 · Cited by 70
Self-citationDelivering on the promise of gene editing for cystic fibrosis
Hodges, C. A., & Conlon, R. A. (2018) · Genes & Diseases · doi:10.1016/j.gendis.2018.11.005 · Cited by 63
Gene disruption through base editing‐induced messenger RNA missplicing in plants
Li, Z., Xiong, X., Wang, F., Liang, J., & Li, J. (2018) · New Phytologist · doi:10.1111/nph.15647 · Cited by 62
Assigning functionality to cysteines by base editing of cancer dependency genes
Li, H., Ma, T., Remsberg, J. R., Won, S. J., DeMeester, K. E., Njomen, E., Ogasawara, D., Zhao, K. T., Huang, T. P., Lu, B., et al. (2023) · Nature Chemical Biology · doi:10.1038/s41589-023-01428-w · Cited by 62
Self-citationNovel therapies for mucopolysaccharidosis type III
Yılmaz, B. Ş., Davison, J. E., Jones, S. A., & Baruteau, J. (2020) · Journal of Inherited Metabolic Disease · doi:10.1002/jimd.12316 · Cited by 61
Functional correction of CFTR mutations in human airway epithelial cells using adenine base editors
Krishnamurthy, S., Traore, S., Cooney, A. L., Brommel, C. M., Kulhánková, K., Sinn, P. L., Newby, G. A., Liu, D. R., & McCray, P. B. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab788 · Cited by 63
Self-citationImprovement of base editors and prime editors advances precision genome engineering in plants
Hua, K., Han, P., & Zhu, J. (2021) · PLANT PHYSIOLOGY · doi:10.1093/plphys/kiab591 · Cited by 62
An update on precision genome editing by homology-directed repair in plants
Chen, J., Li, S., He, Y., Li, J., & Xia, L. (2022) · PLANT PHYSIOLOGY · doi:10.1093/plphys/kiac037 · Cited by 67
Jo, D. H., Jang, H., Cho, C. S., Han, J. H., Ryu, G., Jung, Y., Bae, S., & Kim, J. H. (2022) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2022.11.021 · Cited by 61
DddA homolog search and engineering expand sequence compatibility of mitochondrial base editing
Li, M., Shi, M., Li, Y., Xie, G., Rao, X., Wu, D., Cheng, A., Niu, M., Xu, F., Yu, Y., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-36600-2 · Cited by 65
TIGR-Tas: A family of modular RNA-guided DNA-targeting systems in prokaryotes and their viruses
Faure, G., Saito, M., Wilkinson, M. E., Quinones‐Olvera, N., Xu, P., Flam-Shepherd, D., Kim, S. S., Reddy, N. R., Zhu, S., Evgeniou, L., et al. (2025) · Science · doi:10.1126/science.adv9789 · Cited by 74
Taemaitree, L., Shivalingam, A., El-Sagheer, A. H., & Brown, T. P. (2019) · Nature Communications · doi:10.1038/s41467-019-09600-4 · Cited by 61
Combinatorial mutagenesis en masse optimizes the genome editing activities of SpCas9
Choi, G. C. G., Zhou, P., Yuen, C. T. L., Chan, B. K. C., Xu, F., Bao, S., Chu, H. Y., Thean, D., Tan, K., Wong, K. H., et al. (2019) · Nature Methods · doi:10.1038/s41592-019-0473-0 · Cited by 63
CRISPR system: Discovery, development and off-target detection
Chen, S., Yao, Y., Zhang, Y., & Fan, G. (2020) · Cellular Signalling · doi:10.1016/j.cellsig.2020.109577 · Cited by 60
Prime Editing Technology and Its Prospects for Future Applications in Plant Biology Research
Hassan, M. M., Yuan, G., Chen, J., Tuskan, G. A., & Yang, X. (2020) · BioDesign Research · doi:10.34133/2020/9350905 · Cited by 63
Inda, M. E., & Lu, T. K. (2020) · Annual Review of Microbiology · doi:10.1146/annurev-micro-022620-081059 · Cited by 62
Yang, L., Zhang, X., Wang, L., Yin, S., Zhu, B., Xie, L., Duan, Q., Hu, H., Zheng, R., Yu, W., et al. (2019) · Protein & Cell · doi:10.1007/s13238-019-0631-2 · Cited by 61
CRISPR/Cascade 9-Mediated Genome Editing-Challenges and Opportunities
Roy, B., Zhao, J. C., Yang, C., Luo, W., Xiong, T., Li, Y., Fang, X., Gao, G., Singh, C. O., Madsen, L., et al. (2018) · Frontiers in Genetics · doi:10.3389/fgene.2018.00240 · Cited by 61
GO: a functional reporter system to identify and enrich base editing activity
Katti, A., Foronda, M., Zimmerman, J., Diaz, B. J., Zafra, M. P., Goswami, S., & Dow, L. E. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa124 · Cited by 60
Highly efficient C‐to‐T and A‐to‐G base editing in a Populus hybrid
Li, G., Sretenovic, S., Eisenstein, E., Coleman, G. D., & Qi, Y. (2021) · Plant Biotechnology Journal · doi:10.1111/pbi.13581 · Cited by 60
Recent advances in CRISPR/Cas9 and applications for wheat functional genomics and breeding
Li, J., Li, Y., & Ma, L. (2021) · aBIOTECH · doi:10.1007/s42994-021-00042-5 · Cited by 66
Genetic therapeutic advancements for Dravet Syndrome
Chilcott, E. M., Diaz, J. F. A., Bertram, C., Berti, M., & Karda, R. (2022) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2022.108741 · Cited by 59
Hong, S.-A., Kim, S., Lee, A.-Y., Hwang, G., Kim, J. H., Iwata, H., Kim, S., Bae, S., & Lee, S. E. (2022) · Molecular Therapy · doi:10.1016/j.ymthe.2022.06.005 · Cited by 64
HDAC inhibitors improve CRISPR-Cas9 mediated prime editing and base editing
Liu, N., Zhou, L., Lin, G., Hu, Y. F., Jiao, Y., Wang, Y., Liu, J., Yang, S., & Yao, S. (2022) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2022.05.036 · Cited by 60
Tracking-seq reveals the heterogeneity of off-target effects in CRISPR–Cas9-mediated genome editing
Zhu, M., Xu, R., Yuan, J., Wang, J., Ren, X., Cong, T., You, Y., Ju, A., Xu, L., Wang, H., et al. (2024) · Nature Biotechnology · doi:10.1038/s41587-024-02307-y · Cited by 62
Emerging trends in prime editing for precision genome editing
Lee, J., Kweon, J., & Kim, Y. (2025) · Experimental & Molecular Medicine · doi:10.1038/s12276-025-01463-8 · Cited by 70
CRISPR–Cas9D10A nickase‐assisted base editing in the solvent producer Clostridium beijerinckii
Li, Q., Seys, F. M., Minton, N. P., Yang, J., Jiang, Y., Jiang, W., & Yang, S. (2019) · Biotechnology and Bioengineering · doi:10.1002/bit.26949 · Cited by 60
Stark, J. C., Huang, A., Hsu, K. J., Dubner, R. S., Forbrook, J., Marshalla, S., Rodriguez, F., Washington, M., Rybnicky, G. A., Nguyen, P. Q., et al. (2019) · ACS Synthetic Biology · doi:10.1021/acssynbio.8b00381 · Cited by 61
Wang, J., Zhang, C., & Feng, B. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15039 · Cited by 61
Delivery Approaches for Therapeutic Genome Editing and Challenges
Ates, I., Rathbone, T., Stuart, C., Bridges, P. H., & Cottle, R. N. (2020) · Genes · doi:10.3390/genes11101113 · Cited by 63
Gene Therapy for Lysosomal Storage Disorders: Ongoing Studies and Clinical Development
Massaro, G., Geard, A. F., Liu, W., Coombe-Tennant, O., Waddington, S. N., Baruteau, J., Gissen, P., & Rahim, A. A. (2021) · Biomolecules · doi:10.3390/biom11040611 · Cited by 64
PAM-flexible genome editing with an engineered chimeric Cas9
Zhao, L., Koseki, S. R. T., Silverstein, R. A., Amrani, N., Peng, C., Kramme, C., Savic, N., Pacesa, M., Rodríguez, T. C., Stan, T., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-41829-y · Cited by 59
Annunziato, S., Lutz, C., Henneman, L., Bhin, J., Wong, K., Siteur, B., van Gerwen, B., de Korte‐Grimmerink, R., Zafra, M. P., Schatoff, E. M., et al. (2020) · The EMBO Journal · doi:10.15252/embj.2019102169 · Cited by 62
Evolution and Application of Genome Editing Techniques for Achieving Food and Nutritional Security
Fiaz, S., Ahmar, S., Saeed, S., Riaz, A., Mora, F., & Jung, K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115585 · Cited by 61
The power and the promise of CRISPR/Cas9 genome editing for clinical application with gene therapy
Guo, N., Liu, J., Li, W., Ma, Y., & Fu, D. (2021) · Journal of Advanced Research · doi:10.1016/j.jare.2021.11.018 · Cited by 64
Predicting base editing outcomes using position-specific sequence determinants
Pallaseni, A., Peets, E. M., Koeppel, J., Weller, J., Vanderstichele, T., Ho, U. L., Crepaldi, L., van Leeuwen, J. S., Allen, F., & Parts, L. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac161 · Cited by 59
Metadata
- Authors
- Gaudelli, N. M., Komor, A. C., Rees, H. A., Packer, M. S., Badran, A. H., Bryson, D. I., & Liu, D. R.
- Affiliations
- Broad Institute (US)
- Corresponding author
- Liu, David R.
- ORCID
- Venue
- Nature
- Published
- 2017-11-01
- Volume
- 551
- Issue
- 7681
- Pages
- 464-471
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC5726555
- OpenAlex
- W2766599608
- Cited by
- 4,184
- References
- 46
- Citations by year
- 2026: 460 · 2025: 501 · 2024: 521 · 2023: 599 · 2022: 557 · 2021: 489 · 2020: 474 · 2019: 332 · 2018: 237 · 2017: 8
- FWCI
- 117.56
- Type
- journal article
- Language
- en
- Update notices
- correction (2018-05-02)
- Open access
- green
- europepmc.org
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- RePEc: Research Papers in Economics (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- Howard Hughes Medical Institute
- National Human Genome Research Institute (RM1HG009490)
- National Institute of General Medical Sciences (T32GM008313, F32GM106621, R35GM118062, F32GM112366)
- National Institute of Biomedical Imaging and Bioengineering (R01EB022376)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Keywords
- adenine base editors, base editing, cytosine deamination, CRISPR/Cas9, directed evolution, protein engineering, transition mutations, point mutations, single nucleotide polymorphisms
- MeSH terms
- Gene Editing, Adenosine Deaminase, DNA, Humans, Models, Molecular, Genome, Human, Base Pairing, Polymorphism, Single Nucleotide, Cell Line, Tumor, DNA Cleavage, HEK293 Cells, CRISPR-Associated Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
